RxDoctor Payments Data

Jennifer Johnson

Nurse Practitioner · Narragansett, RINPI 1962588384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 363 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 31.8% of the total. Among nurse practitioner clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,040in general payments, 2019–2025

Across 363 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$1K
  • LEO Pharma Inc.$308
  • E.r. Squibb & Sons, L.L.C.$282
  • Pfizer$269
  • Sanofi$267
  • plus $854 from 11 others

What the payments were for

  • Food & beverage$4,79995%
  • Education$2415%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,040 in reported general payments places this provider in the 95th percentile of 396 nurse practitioner providers in Rhode Island.

See all nurse practitioner providers in Rhode Island

Medicare billing

Part B allowed, 2024
$130,927
Medicare patients
538
Services billed
2,742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate55$1,919
Tacrolimus17$1,868
Fluorouracil33$1,866
Triamcinolone Acetonide147$1,520
Ketoconazole73$1,246
Metronidazole19$951
ValacyclovirValacyclovir Hcl26$613
CiclopiroxCiclopirox Olamine17$521
Ciclopirox15$505
Imiquimod24$442
Clindamycin Phosphate13$414
Mometasone Furoate22$407
Ammonium Lactate13$368
Betamethasone Valerate14$360
Levocetirizine Dihydrochloride19$356

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Narragansett

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →